MELBOURNE & INDIANAPOLIS,  26 March 2018 – Telix Pharmaceuticals announced the submission of a Drug Master File (DMF) for a sterile kit used in the preparation of 68Ga-PSMA-11 (PSMA Kit), to the US Food and Drug Administration (FDA DMF ID: 032631). The full media release can be accessed here